Incyte (INCY) PT Raised to $127 at UBS, Neutral Rating Maintained

October 5, 2026 9:29 AM EDT Send to a Friend
UBS analyst Ashwani Verma raised the price target on Incyte (NASDAQ: INCY) to $127.00 (from $113.00) while maintaining a Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login